30,210 Shares in SPDR S&P Biotech ETF $XBI Purchased by Fischer Investment Strategies LLC

Fischer Investment Strategies LLC bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 30,210 shares of the exchange traded fund’s stock, valued at approximately $3,684,000. SPDR S&P Biotech ETF accounts for 2.1% of Fischer Investment Strategies LLC’s investment portfolio, making the stock its 18th biggest position.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its position in SPDR S&P Biotech ETF by 27.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after buying an additional 2,900,633 shares during the period. Assetmark Inc. boosted its position in shares of SPDR S&P Biotech ETF by 1,042,265.6% in the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after acquiring an additional 635,782 shares during the period. Greenwoods Asset Management Hong Kong Ltd. acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth $55,613,000. Ameriprise Financial Inc. grew its stake in shares of SPDR S&P Biotech ETF by 123.0% in the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after acquiring an additional 481,408 shares during the last quarter. Finally, Meitav Investment House Ltd. increased its position in SPDR S&P Biotech ETF by 70.3% during the third quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock worth $68,156,000 after acquiring an additional 281,602 shares during the period.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $134.49 on Friday. The stock has a market cap of $8.73 billion, a P/E ratio of 11.47 and a beta of 0.88. SPDR S&P Biotech ETF has a one year low of $75.68 and a one year high of $139.19. The company has a fifty day moving average price of $127.28 and a 200 day moving average price of $121.69.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.